Lagas, Jurjen S. et al
"Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment." Clinical Cancer Research
15.7
(2009):
2344-2351.
Web. 10 April. 2021.
